1

CURRICULUM VITAE

DAVID S.H. BELL, M.B., FACP,FRCPEd, FRCPC,FACE

Business Address:

3928 Montclair Road

Suite 130

Mountain Brook, AL 35213

Clinic Telephone: (205) 803.1113

Clinic Fax: (205) 803.1114

E-mail:

Birthplace: N. Ireland

U. S. Citizen

Married Status: Married

Children: Three

EDUCATION:Belfast Royal Academy, 1955-1962

QueensUniversity, Belfast Dental School, 1962-1965

Queens University School of Medicine, 1965-1970

Graduated MB, B. Ch., B.A.O., 1970

POSTGRADUATE TRAINING

Intern in Medicine, RoyalVictoriaHospital, Belfast, 1970-1971

Resident in Internal Medicine, RoyalVictoriaHospital, Belfast, 1971-1973

Resident in Internal Medicine, RoyalUniversityHospital, Saskatoon, Saskatchewan, 1973-74

Fellow in Endocrinology, RoyalUniversityHospital, Saskatoon, Saskatchewan, 1974-1975

Fellow in Endocrinology, Greater Baltimore Medical Center, 1975-1976

FACULTY POSITIONS HELD

Tutor in Medicine, QueensUniversity, Belfast, 1971-1972

Tutor in Pharmacology and Therapeutics, QueensUniversity, Belfast, 1972-1973

Teaching Fellow, University of Saskatchewan, Saskatoon, 1974-1975

Assistant Professor of Medicine, Temple University School of Medicine, 1978-1980

Clinical Assistant Professor of Medicine, PennsylvaniaStateUniversityCollege of Medicine

1978-1980

Associate Professor of Medicine, University of Alabama at Birmingham, 1980-1987

Professor of Medicine, University of Alabama at BirminghamSchool of Medicine 1987-2005

Adjunct Clinical Professor of Medicine, University of Alabama Medical School, Birmingham, AL 2005-present

David S.H.Bell

HONORS

2nd in Class Final Part 1 – 1969

Top 20 in Class Final Part 2 - 1970

Fellow, RoyalCollege of Physicians and Surgeons of Canada, 1976

Fellow, AmericanCollege of Physicians – 1983

Fellow, RoyalCollege of Physicians of Edinburgh – 1986

Birmingham’s Best Doctors -2008-2015

Named in the “The Best Doctors in America”, 2001-2015

Named one of America’s Top Doctors, 2001-2015

Top Doctors for men in Men’s Health, 2007

Top Doctors for women in Women’s Health, 2008

Received the 2001 Distinguished Clinician award from the AmericanCollege of Endocrinology for outstanding contribution to the field of Endocrinology as a master educator and clinician

Received the 2002 Southern Medical Association’s Seale Harris Award for superior contributions to the art and science of diabetes and endocrinology

Top 30% Reviewers for Annals of Internal Medicine -2008

USA Today Most Influential Doctors in Diabetes and Lipids - 2009

America's Most Compassionate Doctors - 2012

BOARD CERTIFICATION

Advanced Achievement in Internal Medicine, 1987

American Board of Internal Medicine (Endocrinology Subspecialty Certification), 1981

American Board of Internal Medicine, 1976

RoyalCollege of Physicians and Surgeons of Canada, 1975

RoyalCollege of Physicians of the United Kingdom, 1973

Professional Organizations

American College of Physicians, member 1977-1982, fellow 1983-present

RoyalCollege of Physicians of Edinburgh, member 1973-1986, fellow 1986-present

RoyalCollege of Physicians and Surgeons of Canada, 1976-present

Endocrine Society, 1990-present

AmericanCollege of Endocrinology, Fellow

American Medical Association, 1978-present

American Diabetes Association, 1978-present

EDITORIAL BOARDS

Endocrine Practice 2000-2005

Treatments in Endocrinology 2001-2005

Diabetes Obesity and Metabolism 2002-present

Endocrine Today 2006-present

David S.H. Bell

ADMINISTRATIVE APPOINTMENTS

District Coroner in Province of Ontario, 1976-1978

ConemaughValleyMemorial Hospital, Johnstown PA

Director, Internal Medicine Residency Program, 1978-1980

Director, Physicians Continuing Education, 1978-1980

University of Alabama at Birmingham

Director of Clinical Services, Diabetes Research and Education Hospital, 1980-1992

Director Adolescent Diabetes Unit 1982-1985

Clinical Director, Endocrinology Clinic, The Kirklin Clinic, 1992-1997

Director, Clinical Research, Division of Endocrinology, 1998-2003

HOSPITAL APPOINTMENTS

GeorgetownMemorialHospital, Georgetown, Ontario, Canada 1976-1978

ConemaughValleyMemorialHospital, Johnstown, PA, 1978-1980

University of Alabama at Birmingham Hospital, 1980-2005

EyeFoundationHospital, Birmingham, AL, 1981-1990

STATE LICENSURE:

General Medical Council of the United Kingdom 1970-1973

Saskatchewan, 1973-1975

Maryland, 1975-1976

Ontario, 1976-1981

Pennsylvania, 1978-1981

Alabama, 1980 – present (License #09301)

David S.H.Bell

PUBLICATIONS

  1. Bell DSH, Moyer JH: Vasodilator drugs for peripheral vascular disturbances. In: Modell W (ed): Drugs of Choice 1980-1981. C.V. Mosby, St. Louis(1980)441-449.
  1. Clements RS Jr, Bell DSH: Diagnostic pathogenetic and therapeutic aspects of diabetic neuropathy. In Special Topics in Endocrinology and Metabolism, Cohen M.P. and Foa P.P. (eds): A.R. Liss, Inc., New York, (1981)1-143.
  1. Pittman W, Acton R, Barger B, Bell DSH, Go R, Murphy C, roseman J: HLA-A, -B, and –DR Associations in Type 1 Diabetes Mellitus with Onset After Age Forty. Diabetes (1982)31:122-125.
  1. Clements RS Jr, Bell DSH: Diabetic Neuropathy. Peripheral and autonomic syndromes. Postgraduate Medicine (1982)71(6) 50-67.
  1. Clements RS Jr, Bell DSH: Candidate mechanism for the pathogenesis of diabetic neuropathy. In: Diabetes and its Late Complications. Cudworth AG, Andreani D, Bodansky HJ, Squadrito G (eds): John Libbey, London (1982)119-126.
  1. Fairclough PK, Clements RS Jr., Filer DV, Bell DSH: An evaluation of patient performance of and their satisfaction with various rapid blood glucose measurement systems. Diabetes Care (1983) 6:45-49.
  1. Bell DSH, Clements RS Jr., : Reversal of the carpal tunnel syndrome after change of insulin injection sites. Diabetes Care (1983)6:45-46.
  1. Bell DSH, Christian SR, Clements RS Jr.: Acuphobia in a long-standing insulin-dependent diabetic cured by hypnosis. Diabetes Care (1983) 6:622.
  1. Bell DSH: Amitriptyline versus placebo in post-herpetic neuralgia. Neurology (1983) 33:1530.
  1. Bell DSH: MIST: Medical Information via Telephone. Alabama Journal of Medical Sciences (1985) 22:311-314.
  1. Bell DSH: Immunotherapy of Diabetes. Dial Access of the Southern Medical Association, 1984.
  1. Bell DSH, Acton R: Immunotherapy of insulin-dependent diabetes. Alabama Journal of Medical Sciences (1985) 22:311-314.
  1. Bell DSH: Exercise guidelines for the diabetic. Sports and Medcina (1985)5:31-33.

David S.H.Bell

  1. Hodge TW, Barger BO, Littrell MN, Bell DSH, Go RCP, Acton RT: DR-B restriction fragment length polymorphisms associated with insulin-dependent diabetes mellitus. Biochemical Society Transaction (1985)79(5A)1-7.
  1. Clements RS Jr, Bell DSH: Diabetic complications – prevalence, detection, current treatment and prognosis. Amer J. Medicine (1985) 79(5A) 1-7.
  1. Clements RS Jr, Bell DSH: Diabetic Neuropathy Part 1. Diabetic Complications (1985) 1:1-3.
  1. Clements RS Jr, Bell DSH: Diabetic Neuropathy Part II. Diabetic Complications (1985) 2:1-4.
  1. Bell DSH, Clements RS Jr: Selection of patients for insulin pump therapy. Practical Cardiology (1986) 12:57-71.
  1. Clements RS Jr, Bell DSH: Intensive insulin therapy – rationale and methods. Research Update (1986) 1:1-8.
  1. Bell DSH, Clements RS Jr.: Rapid insulin initiation in NIDDM: Effect on B-cell function and insulin resistance. Proceedings of 1st International Novo Symposium on Non-Insulin-Dependent Diabetes. Editor, R. Tattersal: (1987)61-66.
  1. Clements RS Jr, Bell DSH, Benbarka A, Capper SA: Rapid insulin initiation in non-insulin dependent diabetes mellitus. Amer J. Medicine (1987)82:415-420.
  1. Hughes TA, Clements RS, Fairclough PK, Bell DSH, Segrest JP: Effect of insulin therapy on lipoproteins in NIDDM. Atherosclerosis (1987) 67:105-114.
  1. Bell DSH, Acton RT, Barger BO, Vanichanan C, Clements RS Jr.: The futility of predicting the onset of insulin-dependent diabetes. Diabetes Care (1987) 10:788-789.
  1. Bell DSH, Clements RSJr.: Diabetes and the digestive system. Diabetes Forecast (1987)12:43-46.
  1. Bartholomew G, Radu B, Bell DSH: Oral candidiasis in insulin-dependent diabetes. Diabetes Care (1987) 10:604-606.
  1. Bell DSH, Ackerson C, Cutter G, Clements RSJr.: Factors associated with discontinuation of continuous subcutaneous insulin. American Journal of Medical Sciences (1988) 295:23-28.

David S.H. Bell

  1. Bell DS, Clements RS, Cutter GR, Whitley RJ. Condylomata acuminata in IDDM. Diabetes Care (1988) 11(3):295-6.
  1. Bell DSH, Clements RS Jr.: Prediction and Immunosuppression of Type 1 Diabetes. Reply, Diabetes Care (1988) 11:511.
  1. Bell DS. Failure to recognize that hypoglycemia may be a problem associated with insulin manufactured by the recombinant DNA method. Clin Ther 1989 11(5)707-708.
  1. Bell DSH: Hypertension in the person with diabetes. American Journal of Medical Sciences. (1989) 297:228-232.
  1. Lauritano AA, Clements RS, Bell DSH: Insulin antibodies in non-insulin-dependent diabetes mellitus: Effect of treatment with semi-synthetic human insulin. Clinical Therapeutics (1989) 2:268-277.
  1. Bell DSH: Improved Treatment of NIDDM: Fixed-Ratio Insulin Regimens in: Making Life Better for the Insulin-Using Patient. A Special Report. Postgraduate Medicine (1989)10:27-34.
  1. Bell DSH: Pathogenesis and Prevention of Insulin-Dependent Diabetes. Southern Medical Association, Dial Access Program, 1989.
  1. Bell DSH: Pentoxifylline in the Treatment of Microcirculatory Disorders. A Review of the Literature. Ed. Bell DSH. Excerpta Medica Princeton, USA(1989)1-4.
  1. Bell DSH: Topics in Clinical Research III. The importance of randomized, double-blind procedures in clinical trials. Clinical Therapeutics (1989)11(5) 652-658.
  1. Clements RS Jr., Bell DSH. Increased responsiveness to exogenous insulin administration in the hypeglycemic obese person with type II diabetes. Clinical Therapeutics (1989) II(5) 652-658.
  1. Bell DSH. The importance of double-blinding. Clinical Therapeutics (1989)11(5)707-708.
  1. Bell DSH, Cutter GR, and Lauritano AA. Efficacy of a premixed semisynthetic insulin regimen. Clinical Therapeutics (1989)11:795-801.

David S.H. Bell

  1. Acton RT, Vanichanan CJ, Perkins L, Go RCP, Roseman JM, Barger BO, Bell DSH, Goldenberg RL, Winkler CL, Tucker JM, Hauth JC, and Huddleston JF. Immunogenetic Predictors of Gestational Diabetes in American Blacks in Immunology of Normal and Diabetic Pregnancy, edited by D. Andreani, GD Bompiani, U Di Mario, S.P. Faulk and A. Galluzzo. John Wiley & Sons LTD (1990) Chapter 12, Pages 207-220.
  1. Bell DSH. Sulfonylurea failure in non-insulin-dependent diabetes mellitus. American Journal of Medicine (1990)89:446-447.
  1. Bell DSH, Clements RS Jr., Perentesis GP. Hypoglycemia in children with insulin-dependent diabetes mellitus. J. Pediatr (1990) 117:340.
  1. Bell DSH, Barger BO, Go RCP, Goldenberg RL, Perkins LL, Vanichanan CJ, Roseman J, Acton RT. Risk factors for gestational diabetes in the black population. Diabetes Care (1990) 13(11):1196-1201.
  1. Bell DSH. Hazards of Inaccurate Readings Obtained by Self-Monitoring of Blood Glucose. Diabetes Care (1990) 13:1131-1132.
  1. Williams BT, Ketchum CH, Robinson A, and Bell DSH. Screening for slight albuminuria: A comparison of selected commercially available methods. Southern Medical Journal (1990) 83:1447-1449.
  1. Bell DSH. Diabetic nephropathy: Changing concepts of pathogenesis and treatment. The American Journal of the Medical Sciences (1991) 301:195-200.
  1. Tucker JM, Winkler CL, Hauth JC, Goldenberg RL, Acton RT, Barger BO, Go RCP, Bell DSH, Perkins LL, Vanichanan CJ, and Roseman JM. Autoantibodies in black women with class A1 or class GB diabetes mellitus. American Journal of Perinatology (1991) 8:103-105.
  1. Winkler CL, Tucker JM, Hauth JC, Goldenberg RL, Acton RT, Barger BO, Go RCP, Bell DSH, Perkins LL, Vanichanan CJ, and Roseman JM. Histocompatability antigen subtypes in black women with class A1 or Class GB diabetes mellitus. American Journal of Perinatology (1991) 8:106-109.
  1. Bell DSH. Lower limb problems in diabetic patients. What are the causes? What are the remedies? Postgraduate Medicine (1991) 89:237-244.
  1. Bell DSH, Bode B, Clements RS Jr., Herron J, Hollander P, Kumar D, Perentesis GP, Sosenko J. Premixed vs. Self-mixed insulin in the treatment of type II diabetes mellitus: A randomized trial. Today’s Therapeutic Trends. The Journal of New Developments in Clinical Medicine (1991) 9:63-73.

David S.H. Bell

  1. Bell DSH, Clements RS, Perentesis G, Roddam R, and Wagenknecht L. Dosage accuracy of self-mixed vs. premixed insulin. Archives of Internal Medicine (1991) 151:2265-2269.
  1. Bell DSH, Wagenknecht LE. Effect of gemfibrozil on intermediate density lipoproteins in NIDDM patients. Diabetes Care (1992) 15:146-147.
  1. Aikens JE, Wallander JL, Bell DSH, and Cole JA. Daily stress variability, learned resourcefulness, regimen adherence, and metabolic control in type 1 diabetes mellitus: Evaluation of a path model. Journal of Consulting and Clinical Psychology (1992) 60:113-118.
  1. Roseman JM, Go RCP, Perkins L, Barger B, Bell DSH, Goldenberg RL, DuBardMB, Huddleston JF, Sedlacek CM, and Acton RT. Gestational diabetes mellitus among African-American women. Diabetes/Metabolism Reviews (1991) 93-104.
  1. Bell DSH, Ketchum CH, Robinson CS, Wagenknecht LE, Williams BT. Microalbuminuria associated with diabetic neuropathy. Diabetes Care (1992) 15:528-531.
  1. Bell DSH. Hypoglycemia induced by Enalapril in patient with insulin resistance and NIDDM. Diabetes Care (1992)15:934-935.
  1. Bell DSH. Milk allergy masquerading as insulin allergy. Diabetes Care (1992) 15:934-935.
  1. Bell DSH. Diabetic nephropathy associated with insulin-dependent diabetes. Internal Medicine (2) (1992) Medifacts, OttawaCanada.
  1. Bell DSH. Exercise for patients with diabetes – benefits, risks, and precautions. Postgraduate Medicine (1992) 92:183-198.
  1. Bell DSH, Cutter GR, Hayne VB, and Lloyd LK. Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in the diabetic male. Urology (1992) 40:36-40.
  1. Bell DSH. Diabetic foot problems. Family Practice (1992) 2(6). Medifacts Ottawa, Canada.
  1. Bell DSH. Diabetes and hypertension – prevalence and therapy. Cardiology (1992) (6). Medifacts Ottawa, Canada.

David S.H. Bell

  1. Bell DSH, Cutter G, Clements RS, Jr. The feasibility of long-term treatment of diabetes with continuous subcutaneous insulin infusion. Diab. Nutr. Metab. (1993) 6:57-60.
  1. Bell DSH. Insulin resistance: an often unrecognized problem accompanying chronic medical disorders. Postgraduate Medicine (1993) (937) 99-107.
  1. Acton RT, Bell DSH, Go RC, Roseman J. Association of HLA phenotypes with hypertension in African Americans and Caucasoid Americans with type II diabetes, a population at risk for renal disease. Transplant Proc (1993) 25:2400-2403.
  1. Bell DSH. The graveyard shift. Diabetes Forecase (1994) 47:47-49.
  1. Chiu KC, Go RCP, Aoki M, Riggs AC, Tanizawa Y, Acton RT, Bell DSH, Goldenerg RL, Roseman JM, Permutt MA. Glucokinase gene in gestational diabetes mellitus: population association study and molecular scanning. Diabetologia (1994) 37:104-110.
  1. Bell DSH. Stroke in the diabetic patient. Diabetes Care (1994) 17:217-219.
  1. Bell DSH, Cutter G. Characteristics of severe hypoglycemia in the patient with insulin-dependent diabetes. Southern Medical Journal (1994) 87(6)616-620.
  1. Bell DSH. Insulin pump therapy for the 90’s. The Endocrinologist (1994) (4)270-278.
  1. Acton RT, Roseman JM, Bell DSH, Goldenberg RL, Tseng ML, Vanichanan LA, Harman LA, Go RCP. Genes within the major histocompatibility complex predict NIDDM in African American Women in Alabama. Diabetes Care (1994) 17:1491-1494.
  1. Bell DSH. Stopping those swinging sugars. Diabetes Forecast (1994)47:36-40.
  1. Tanizawa Y, Riggs AC, Chiu KC, Janssen RC, Bell DSH, Go RPC, Roseman JM, Acton RT, Permutt MA. Variability of the pancreatic islet beta cell/liver (GLUT 2) glucose transporter gene in NIDDM patients. Diabetologia (1994) 420-427.
  1. Aikens JE, Wallander JL, Bell DS, McNorton A. A nomothetic-idiographic study of daily psychological stress and blood glucose in women with type 1 diabetes mellitus. J Behav Med (1994) 17(6)535-48.
  1. Bell DSH. Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease? Diabetes Care (1995) 18:708-714.

David S.H. Bell

  1. Bell DSH. To hurt or not to hurt. Diabetes Forecast (1995) 48(6)30-33.
  1. Bell DSH. How to manage stroke in patients with diabetes: Strategies for diagnosis, treatment and prevention. The Journal of Critical Illness (1995) 10(5)317-328.
  1. Bell DSH. Myocardial infarction and stroke in diabetic patients. Diabetes Metabolism. (1995) 40:1-4.
  1. Bell DSH. Lack of long-term diabetic complications in spite of poor glycemic control in twins with pure gonadal dysgenesis. Diabetes Care (1995) 18:1286-1287.
  1. McCarren M, Bell DSH. Prepare to pump. Diabetes Forecast (1995) September 33-39.
  1. Bell DSH, Grizzle WE, DunlapNE. Nesidoblastosis causing reversal of insulin-dependent diabetes and development of hyperinsulinemic hypoglycemia. Diabetes Care (1995) 18:1379-1380.
  1. Bell DSH. Night shift work and the diabetic patient. The Endocrinologist (1995) 5:344-346.
  1. Bell DSH. Non-diabetic neuropathy in a patient with diabetes. Endocrine Practice (1995) 1(6) 393-394.
  1. Bell DSH. A comparison of lovastatin, an HMG-COA reductase inhibitor, with gemfibrozil, a fibrinic acid derivative, in the treatment of patients with diabetic dyslipidemia. Clinical Therapeutics (1995) 17:901-910.
  1. Bell DSH, Yumuk VD. Low incidence of false-positive exercise thallium 201 scintigraphy in a diabetic population. Diabetes Care (1995) 19(2)185.
  1. Bell DSH. Profiles of stroke in the diabetic patient. Advances in Cardiovascular Medicine (1996) 3:1-8.
  1. Bell DSH. Alcohol and the NIDDM patient. Diabetes Care (1996) 19:509-513.
  1. Bell DSH. Myocardial infarction in the diabetic patient. The Endocrinologist (1996) 6:196-206.
  1. Bell DSH, Acton RT. Increased prevalence of mitral valve prolapse in IDDM. Diabetes Care (1996) 19:672.

David S.H. Bell

  1. Bell DSH. Diabetes mellitus and coronary artery disease. Coronary Artery Disease (1996) 7(10)715-722.
  1. Decrease in mortality from diabetic nephropathy in Pima Indians. Diabetes Care (1996) 19:779.
  1. Bell DSH, Mayo MS. Outcome of metformin-facilitated reinitiation of oral diabetic therapy in insulin-treated patients with non-insulin-dependent diabetes mellitus. Endocrine Practice (1997) 3:73-76.
  1. Bell DSH, Alele J. Diabetic ketoacidosis. Postgraduate Medicine (1997) 101:193-203.
  1. Bell DSH. New modalities for the treatment of NIDDM: Acarbose and metformin. Consultant Pharmacist 12(suppl A)7-11,1997.
  1. Bell DSH. Management of Diabetes: Medications. In Diabetes Medical Nutrition Therapy. Holler HJ, Pastors JG, Eds. The American Dietetic Association (1997) 35-42.
  1. Bell DSH. Management of Diabetes: Complications. In Diabetes Medical Nutrition Therapy. Holler JH, Pastors JG, Eds. The American Dietetic Association (1997) 75-82.
  1. Bell DSH. Diabetes mellitus and coronary artery disease. Journal of Cardiovascular Risk (1997) 4(2)83-90.
  1. Bell DSH, Yumuk V. Frequency of severe hypoglycemia in patients with non-insulin-dependent diabetes mellitus treated with sulfonylureas or insulin. Endocrine Practice (1997) 3:281-283.
  1. Bell DSH. Converting patients with type 2 diabetes from insulin-requiring to non-insulin-requiring. Clinical Diabetes (1997) 15(5) 205-207.
  1. Bell DSH. Reinitiation of oral hypoglycemic therapy – the Alabama Experience in Proceedings of the Combined Insulin/Oral Agent Therapy: Satellite Symposium to the 1997 Postgraduate Meeting – Baylor College of Medicine, Houston, TX (1997) 29-34.
  1. Bell DSH. Effective Analgesia. BMJ (1997) 315:1411.

David S.H. Bell

  1. Acton RT, Bell DSH, Collins JN, Go RCP, Harrison R, McDonald R, Rivers C, Roseman JM, Taylor HA, and Vanichanan C. Genes within and flanking the major histocompatibility region are risk factors for diabetes, insulin resistance, hypertension, and microalbuminuria in African-American women. Transplantation Proceedings (1997) 29:3710-3712.
  1. Bell DSH. University Group Diabetes Program – “Déjà vu all over again?" Endocrine Practice (1998) 4:6465.
  1. Bell DSH, Mayo MS. Improved glycemic control with use of oral hypoglycemia therapy with or without insulin. Endocrine Practice (1998) 4(2)82-85.
  1. Bell DSH. Managing type 2 diabetes patients who require insulin. In Successful Strategies for the Control of Type 2 Diabetes. Eds. Garber AJ, Bell DSH, Reasner C, James W. Postgraduate Institute for Medicine. Littleton, CO 1998 10-13.
  1. Ovalle F, Bell DSH. Triple oral antidiabetic therapy in type 2 diabetes mellitus. Endocrine Practice (1998) 4:146-147.
  1. Bell DSH, Kudlow J, Tidwell M. Health-care charges generated by patients with diabetes. Endocrine Practice (1998) 4:237-239.
  1. Garber A, Bell DSH, Reasner C. Successful Strategies for the control of type II Diabetes. BaylorCollege of Medicine and Postgraduate Institute for Medicine. A Clinical Monograph. Editor, William E. James. 1998.
  1. Bell DSH. Prudent utilization of the presently available treatment modalities for type 2 diabetes. The Endocrinologist (1998) 8:332-341.
  1. Bell DSH, Ovalle F. Metformin lowers lipoprotein (a) levels. Diabetes Care (1998) 21:2028.
  1. Bell DSH, Ovalle F. Troglitazone interferes with gemfibrozil’s lipid-lowering action. Diabetes Care (1998) 21:2028-2029.
  1. Bell DSH, Mayo MS. Weight loss in patients treated with a metformin-sulfonylurea combination in comparison with twice daily mixed insulin. Endocrine Practice (1998) 4:360-364.
  1. Bell DSH, Ovalle F. Using combination therapy for type 2 diabetes. IM Internal Medicine (1999) 20:20-27.
  1. Bell DSH. Use of B-Adreneregic blocking agents with diabetes – friend and foe. Endocrine Practice (1999) 5:5l-53.

David S.H. Bell

  1. Bell DSH, Alele J. Dealing with diabetic nephropathy. Postgraduate Medicine (1999) 105:83-94.
  1. Bell DSH, Ovalle F. Gastroparesis cured by gastrectomy. Diabetes Care (1999) 22(6)1000-1001.
  1. Bell DSH, Ovalle F. C-peptide utilization in clinical practice: Effect on treatment and outcome of diabetes in a series of cases. Endcrine Practice (1999) 5(3):114-118.
  1. Bell DSH, Ovalle F. Stroke management in the diabetic patient. The Journal of Critical Illness (1999) 14:309-318.
  1. Ovalle F, Bell DSH. Troglitazone’s effect on lipoprotein(a). Diabetes Care (1999) 22:859-860.
  1. Bell DSH, Ovalle F. Is gastroparesis in diabetes cured by gastrectomy? Response to Schnedl et al. Diabetes Care (1999) 22:1921.
  1. Bell DSH, Ovalle F. Advances in therapy for type 2 diabetes. Patient Care (1999) 33:189-200.
  1. Ovalle F, Bell DSH. Hormone replacement therapy and serum uric acid. Lancet (1999) 354:1643-44.
  1. Bell DSH, Ovalle F. Late-onset troglitazone-induced hepatic dysfunction. Diabetes Care (2000) 23:128-129.
  1. Feld S, Hellman R, Dickey RA, Jellinger PS, Janick JJ, Rodbard HW, Cobin RH, Bell DSH, Ganda O, Davidson ET, Siebel JA. AACE Diabetes Guidelines. Endocrine Practice (2000) 6:42-84.
  1. Bell DSH. Should anti-glutamic acid decarboxylase antibody levels be determined in new-onset diabetes? Endocrine Practice (2000) 6(2)214-216.
  1. Bell DSH. DunluceCastle, County Antrim, Northern Ireland. The New England Journal of Medicine (2000) 342(5)324.
  1. Bell DSH. Inflammation, Insulin Resistance, Infection, Diabetes and Atherosclerosis. Endocrine Practice (2000)6:271-275.

David S.H. Bell